Rathmell: To improve funding outlook, we must reverse distrust in science

DOD Melanoma Research Program funding opportunities for FY24

The FY24 Defense Appropriations Act is anticipated to provide funding for the Melanoma Research Program to support innovative, high-impact melanoma research.

May 17, 2024

Vol.50 No.20

Clinical Roundup

AACR publishes Cancer Disparities Progress Report 2024

The American Association for Cancer Research has released its Cancer Disparities Progress Report 2024.

May 17, 2024

Vol.50 No.20

Clinical Trials & Tribulations

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

Tumor heterogeneity is a well-recognized hurdle to successful cancer therapy, often leading to resistance and treatment failure.

May 10, 2024

Vol.50 No.19

By Sanju Sinha and Eytan Ruppin

In Brief

NCI renews MUSC Hollings support grant with “outstanding” rating

NCI has renewed MUSC Hollings Cancer Center’s five-year Cancer Center Support Grant, with an overall rating of “outstanding.”

April 19, 2024

Vol.50 No.16

Clinical

Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials

An analysis by researchers from the International Agency for Research on Cancer casts doubt on validity of an endpoint used in key studies of multi-cancer detection tests.

NCI creates Cancer Equity Leaders group to improve cancer health equity

To address inequities in cancer health, NCI is collaborating with a diverse team of experts and cancer center directors—named the Cancer Equity Leaders (CEL)—to learn from communities and inform workforce development as well as outreach initiatives.

April 12, 2024

Vol.50 No.15

By Matthew Bin Han Ong